Long-term results of a prospective phase II trial of medically inoperable stage I NSCLC treated with SBRT – the Nordic experience
Author:
Publisher
Informa UK Limited
Subject
Radiology Nuclear Medicine and imaging,Oncology,Hematology,General Medicine
Link
http://www.tandfonline.com/doi/pdf/10.3109/0284186X.2015.1020966
Reference22 articles.
1. Prognostic Factors in Stereotactic Body Radiotherapy for Non–Small-Cell Lung Cancer
2. Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame
3. Stereotactic Body Radiation Therapy for Inoperable Early Stage Lung Cancer
4. Outcome in a Prospective Phase II Trial of Medically Inoperable Stage I Non–Small-Cell Lung Cancer Patients Treated With Stereotactic Body Radiotherapy
5. Stereotactic body radiotherapy for medically inoperable patients with stage I non-small cell lung cancer – A first report of toxicity related to COPD/CVD in a non-randomized prospective phase II study
Cited by 71 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. New diagnostic and nonsurgical local treatment modalities for early stage lung cancer;Lung Cancer;2024-10
2. A Dosimetric Comparison of Stereotactic Body Radiation Therapy for Lung Tumors: Plans of Gamma Knife, and Volumetric Modulated Arc Therapy, Dynamic Multileaf Collimator Plans based on Linear Accelerator;2024-07-22
3. Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience;Radiation Oncology;2024-06-16
4. Stereotactic body radiation therapy is beneficial for a subgroup of patients with urothelial cancer and solitary metastatic disease: a single institution real-world experience;2024-04-30
5. Combined surgery and radiotherapy for synchronous multiple primary lung cancers: a clinical retrospective study;2023-09-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3